PCN210 RESOURCE UTILIZATION AND COST FOR WOMEN WITH ADVANCED HR+/HER2- BREAST CANCER IN COLOMBIAN HEALTH CARE SETTINGSSandra Franco, N. Castaño Gamboa, Graciela Rojas et al.|Value in Health|2019Cited by 6
PIN66 COST-EFFECTIVENESS ANALYSIS OF CEFTAZIDIME-AVIBACTAM VERSUS COLISTIN-MEROPENEM IN THE TREATMENT OF INFECTIONS DUE TO CARBAPENEM-RESISTANT ENTEROBACTERIACEAE IN COLOMBIAF.A. Varon, Elkin Lemos, N. Castaño Gamboa et al.|Value in Health|2019Cited by 1
PCN365 CLINICAL CHARACTERISTICS AND MANAGEMENT COSTS OF FEBRILE NEUTROPENIA IN ONCOLOGY PATIENTS IN A HEALTH CARE INSTITUTION IN COLOMBIAIsabel Lema, Sara Mora, Beatriz Preciado et al.|Value in Health|2020Cited by 0
PMS46 USE OF HEALTHCARE RESOURCES IN A COHORT OF COLOMBIAN PATIENTS TREATED WITH BIOLOGIC DISEASE-MODIFYING ANTIRHEUMATIC DRUGS OR TOFACITINIB, 2014–2018Manuel Enrique Machado‐Duque, J Machado-Alba, N. Castaño Gamboa et al.|Value in Health|2020Cited by 0
PCN358 DEMOGRAPHIC, CLINICAL CHARACTERISTICS, TREATMENT PATTERNS AND CLINICAL OUTCOMES BY LINES OF TREATMENT IN HR+/HER2− ADVANCED BREAST CANCER IN COLOMBIASandra Franco, J.M. Reyes Sanchez, Samantha K. Kurosky et al.|Value in Health|2020Cited by 0